Oncolytics Biotech, Inc.’s (ONCY) MACD indicator has entered into bearish territory with a reading of -0.0150. The Zacks #4 Rank (“Sell”) stock decreased slightly to $6.10 in morning trade. The Zacks Consensus Estimate for the year ended 2010 has worsened by a cent over the past one month to a loss of 29 cents per share.
 
ONCOLYTICS BIO (ONCY): Free Stock Analysis Report
 
Zacks Investment Research